The injection is often used to alleviate symptoms associated with various forms of neuropathy, including diabetic neuropathy, alcoholic neuropathy, and drug-induced neuropathy
It supports the health of your nervous system by maintaining the protective covering (myelin) around your nerves
Clinical experience suggests good tolerability, with: Mild injection site reactions Occasional digestive changes (particularly with oral administration) Rarely reported headache Important Safety Considerations Both peptides should be prescribed and monitored by qualified medical providers Quality of peptide sourcing matters compounding pharmacies should be licensed and regulated Lab monitoring (particularly IGF-1 for sermorelin) is essential for ongoing safety Contraindications (active malignancies, certain medical conditions) must be evaluated Medical Disclaimer Sermorelin was previously FDA-approved for diagnostic use (Geref Diagnostic) and is currently prescribed off-label through compounding pharmacies
The Category-2 prohibition on BPC-157 by name is gone, but final FDA action on its 503A listing is still pending
No, there is no established clinical evidence that B12 injections cause weight loss in individuals with normal B12 levels
Shaking instead of swirling , mechanical stress breaks the peptide structure